Ovarian cancer Quality Performance Indicators
Patients diagnosed from October 2019 to September 2022

About this release

This release by Public Health Scotland (PHS) presents performance against the National Ovarian Quality Performance Indicators (QPIs) in the Cancer QPIs dashboard held within the Scottish Cancer Registry and Intelligence Service (SCRIS).

Main points

• There were 483 patients diagnosed with Ovarian cancer in Scotland between October 2021 and September 2022. This is an increase from the previous years (461 diagnosed from October 2020 to September 2021 and 441 from October 2019 to September 2020).
• At Scotland level for October 2021 to September 2022, the target was met for seven of the 11 indicators.

NHS Scotland performance against ovarian quality performance indicators for Oct 19 to Sep 22. QPI 2: 95% target met throughout. QPI 3: 95% target not met in 19/20 or 20/21 but met in 21/22. QPI 4: 90% target met in 19/20 but not met in 20/21 or 21/22. QPI 6: 90% target met throughout. QPI 7: 90% target met throughout. QPI 9: QPI not in use in 19/20. 90% target not met in 20/21 or 21/22. QPI 10(i): 65% target not met throughout. QPI 10(ii): 60% target met throughout. QPI 10(iii): 60% target met throughout. QPI 11: 90% target not met throughout. QPI 12: <5% target met throughout.

Close

Ovarian QPIs

• The QPI results indicate that overall, the quality of ovarian cancer services across Scotland is excellent, particularly in relation to CT or MRI prior to commencing treatment, complete pathology reporting, achieving no residual disease following surgery (or delayed surgery following chemotherapy) for advanced disease and no 30-day mortality following surgery.
• There remains room for further service improvement around first-line chemotherapy, surgery for advanced disease and referral for genetic testing.
• While the target was not achieved for QPI 10(i) over the past three years, there were varying rates of surgery between the regions and when patients did receive surgery the surgery was done well with good rates of cytoreduction achieved (10(ii) and 10(iii)).
• Encouragingly, improvements can be seen over the last year for MDT discussion (QPI 3) and first-line chemotherapy (QPI 9).

Background

National cancer quality performance indicators have been developed to support continuous quality improvement in cancer care (CEL 06 2012). NHS Boards are required to report these indicators against a clinically agreed indicator specific target as part of the mandatory national cancer quality programme. They have been developed collaboratively by North Cancer Alliance, South East Scotland Cancer Network, West of Scotland Cancer Network, Healthcare Improvement Scotland and PHS.

Further information

• The Cancer QPIs dashboard is restricted and may be accessed with permission via https://useraccess.nhsnss.scot.nhs.uk
• Network Reports on Ovarian QPIs: NCA, SCAN and WoSCAN
• QPI Definitions and updates on Ovarian indicators
• PHS QPI Publications

The QPI publications look at a three year period and for that reason the next release of this publication will be in February 2027.